Caricamento...
Combating acquired resistance to tyrosine kinase inhibitors in lung cancer
The prospective identification and therapeutic targeting of oncogenic tyrosine kinases with tyrosine kinase inhibitors (TKIs) has revolutionized the treatment of patients with non-small cell lung cancer (NSCLC). TKI therapy frequently induces dramatic clinical responses in molecularly defined cohort...
Salvato in:
| Pubblicato in: | Am Soc Clin Oncol Educ Book |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4734636/ https://ncbi.nlm.nih.gov/pubmed/25993168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14694/EdBook_AM.2015.35.e165 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|